Domov › Kronična limfocitna levkemija › North Carolina › Durham
Klinične študije za Kronična limfocitna levkemija v Durham, NC
27 študij za Kronična limfocitna levkemija išče udeležence na lokacijah v Durham in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Vključevanje udeležencevFaza 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi stran
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Durham VA Medical Center, Durham
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Vključevanje udeležencevFaza 3
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi stran
- University of North Carolina-Hillsborough Campus, Hillsborough · 13 mi stran
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
Vključevanje udeležencevFaza 3
- University of North Carolina At Chapel Hill, Chapel Hill · 10 mi stran
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
Vključevanje udeležencevFaza 3
- Duke University Medical Center, Durham
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Vključevanje udeležencevFaza 3
- Duke University Medical Center, Durham
- University of North Carolina At Chapel Hill, Chapel Hill · 10 mi stran
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Vključevanje udeležencevFaza 3
- Duke University, Durham
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
Vključevanje udeležencevFaza 2
- Duke University, Durham
Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia
Vključevanje udeležencevFaza 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi stran
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Vključevanje udeležencevFaza 1/2
- UNC School of Medicine, Division of Hematology, Chapel Hill · 10 mi stran
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Vključevanje udeležencevFaza 1/2
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · 10 mi stran
Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± Obinutuzumab
Vključevanje udeležencevFaza 2
- Research Site, Durham
A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
Vključevanje udeležencevFaza 1
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi stran
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Vključevanje udeležencevFaza 1
- Duke University Medical Center, Durham
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
Vključevanje udeležencev
- North Carolina Basnight Cancer Hospital, Chapel Hill · 10 mi stran
Registry of Older Patients With Cancer
Vključevanje udeležencevOpazovalna študija
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi stran
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Vključevanje udeležencevFaza 1
- University of North Carolina, Chapel Hill · 10 mi stran
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Vključevanje udeležencevFaza 4
- Duke University Medical Center, Durham
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
Vključevanje udeležencevFaza 4
- Duke University Medical Center, Durham
Study of SGR-1505 in Mature B-Cell Neoplasms
Vključevanje udeležencevFaza 1
- Duke University, Durham
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Vključevanje udeležencevFaza 2
- University of North Carolina /ID# 233313, Chapel Hill · 10 mi stran
Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation
Vključevanje udeležencevFaza 2
- The University of North Carolina at Chapel Hill, Chapel Hill · 10 mi stran
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
Vključevanje udeležencevFaza 1
- Duke University, Durham
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Vključevanje udeležencevOpazovalna študija
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi stran
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Vključevanje udeležencevFaza 2
- Durham VA Medical Center, Durham, NC, Durham
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
Vključevanje udeležencevFaza 1
- University of North Carolina, Chapel Hill · 10 mi stran
CAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia
Vključevanje udeležencevFaza 1
- Duke University, Durham
Študije za Kronična limfocitna levkemija v drugih mestih
- Boston, MA31 študij
- Columbus, OH28 študij
- Washington, DC22 študij
- Seattle, WA20 študij
- Rochester, MN19 študij
- New York City, NY18 študij
- Houston, TX17 študij
- Baldwin Park, CA16 študij
- Milwaukee, WI15 študij
- Chicago, IL14 študij
- Cincinnati, OH14 študij
- Nashville, TN13 študij
Druge študije v Durham
- Rak dojke63 študij
- Rak (vse vrste)58 študij
- Nemalicelični pljučni rak39 študij
- Množni mielom37 študij
- Metastatski rak33 študij
- Akutna mieločna levkemija33 študij
- Rak pljuč32 študij
- Rak prostate32 študij
- Kolorektalni rak28 študij
- Rak jajčnikov27 študij
- Srčno popuščanje26 študij
- Rak trebušne slinavke24 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.